RUBICON RESEARCH LIMITED (RUBICON) Share Price Rises 2.12% Today

Published: 31 August 2026 at 12:19:31 PM IST

RUBICON Share Price moved higher today, with the stock rising 2.12% to Rs 1,844.00 from the previous close of Rs 1,805.80. The company’s market capitalisation stood at Rs 29,891.75 crore, placing the move in the context of a sizeable listed healthcare name rather than a purely speculative counter. The day’s range was Rs 1,782.25 to Rs 1,852.50, while the open was Rs 1,819.30, giving a clear picture of how RUBICON Share Price behaved through the session. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking RUBICON Stock News or RUBICON News Today, the most useful next checks are valuation, sector comparison and whether the move aligns with the company’s broader financial profile on Univest. Because the move was measured rather than extreme, the session is best read as a positive price update supported by straightforward market data rather than a headline tied to a disclosed announcement.

RUBICON Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,844
Previous Close	Rs 1,805.8
Today's Move	Rs 38.2 (+2.12%)
Open	Rs 1,819.3
High	Rs 1,852.5
Low	Rs 1,782.25
Turnover	Rs 3.41 crore
Market Capitalisation	Rs 29,891.75 crore
Market Cap Category	Large Cap

RUBICON RESEARCH LIMITED (RUBICON) rose to Rs 1,844 from the previous close of Rs 1,805.8, a move of Rs 38.2 or 2.12%. The stock opened at Rs 1,819.3, reached a high of Rs 1,852.5, recorded a low of Rs 1,782.25.

RUBICON Share Price showed a clean upward bias through the session. After opening at Rs 1,819.30, the stock moved above the opening level and ultimately finished at Rs 1,844.00, which was also above the previous close of Rs 1,805.80. That sequence matters because it shows the stock held onto gains into the close rather than giving them back.

The day’s low of Rs 1,782.25 came below the previous close, so the stock did briefly trade in weaker territory. However, the recovery toward the upper end of the range suggests that buyers were able to absorb early softness. The high of Rs 1,852.50 remained close to the closing price, which indicates RUBICON Share Price spent much of the later part of trade near its stronger levels.

Turnover stood at Rs 3.41 crore, which gives a basic sense of market activity for the day without adding any unsupported interpretation. The important point is not just that RUBICON Share Price rose, but that the close was near the day’s high and clearly above the prior session’s reference point. For an event-based update, that is the strongest factual signal available in the data.

In practical terms, today’s session shows a stock that opened slightly above the previous close, slipped to a lower intraday point, and then recovered enough to end with a 2.12% gain. That pattern is the core reason this price rise stands out in RUBICON Share Price Today coverage. It is also why the move should be viewed through the lens of price action first, then fundamentals and peers second.

RUBICON Share Price closed at Rs 1,844.00 after adding Rs 38.20 on the day. The stock opened at Rs 1,819.30, moved between Rs 1,782.25 and Rs 1,852.50, and finished above the previous close of Rs 1,805.80. Turnover stood at Rs 3.41 crore. This confirms a same-day price rise in RUBICON Stock News without assigning a cause that the supplied data does not verify. For investors following RUBICON Share Price Today, the main factual takeaway is that the stock ended near the upper part of the day’s range and above its prior close, which is the core event captured in today’s share price rise.

RUBICON RESEARCH LIMITED (RUBICON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 29,891.75 crore
P/E Ratio	103.71x
P/B Ratio	22.27x
ROE	27.84%
ROCE	29.22%
EPS	Rs 17.41
Book Value Per Share	Rs 81.09
Dividend Yield	0.08%

RUBICON RESEARCH LIMITED (RUBICON) fundamental metrics show P/E 103.71x, P/B 22.27x, ROE 27.84%, ROCE 29.22%. These figures provide context only and are not a buy or sell signal.

RUBICON RESEARCH LIMITED has a market capitalisation of Rs 29891.75 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 103.71x, P/B at 22.27x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.21x, median ROE of 11.78%, median ROCE of 13.6%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	103.71x
Benchmark Median P/E	31.21x
Benchmark Average P/E	48.1x
Benchmark P/E Range	3.7x to 672.45x
Company P/B Ratio	22.27x
Benchmark Median P/B	2.88x
Company ROE	27.84%
Benchmark Median ROE	11.78%
Company ROCE	29.22%
Benchmark Median ROCE	13.6%
Company Market Capitalisation	Rs 29,891.75 crore
Benchmark Median Market Cap	Rs 670.73 crore

RUBICON RESEARCH LIMITED (RUBICON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 103.71x, which is above the benchmark median of 31.21x, a difference of +232.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

RUBICON RESEARCH LIMITED (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.78%, a difference of +136.33%. RUBICON RESEARCH LIMITED (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.6%, a difference of +114.85%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,60,696.31	38.09	5.33	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,46,062.83	84.12	13.93	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,91,515.22	87.81	21.34	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,18,403.7	26.24	4.39	19.69	21.39
Cipla Ltd.	CIPLA	1,14,554.33	33.99	3.26	11.83	16

RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 103.71x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.84% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH LIMITED (RUBICON) has a market capitalisation of Rs 29,891.75 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching RUBICON

• RUBICON Share Price rose 2.12% today to Rs 1,844.00 after a previous close of Rs 1,805.80.
• The day’s range was Rs 1,782.25 to Rs 1,852.50, and the open was Rs 1,819.30.
• Market capitalisation stood at Rs 29,891.75 crore, placing RUBICON in a large listed healthcare profile by market value.
• P/E of 103.71 and P/B of 22.27 show a premium valuation against the supplied healthcare benchmark and peer set.
• ROE of 27.84% and ROCE of 29.22% are above the supplied sector median and average figures.

About RUBICON

RUBICON RESEARCH LIMITED operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not break out product lines, revenue mix or segment details, so the most reliable company profile here is the listed classification itself and the financial footprint attached to it. With a market capitalisation of Rs 29,891.75 crore, RUBICON sits among higher-valued listed healthcare companies in India.

For readers using Univest to review RUBICON Share Price, the key company context today is its combination of a premium valuation, strong profitability ratios and a position inside a broad pharmaceuticals universe of 203 companies. That makes RUBICON Share Price relevant not just as a one-day move, but also as a stock where price action needs to be read alongside fundamentals, sector benchmarks and peer comparisons. In Univest coverage, this is the kind of stock where RUBICON Company News, RUBICON Stock Performance and RUBICON Share Price Update are best understood together. The company summary remains intentionally concise because the supplied dataset is limited to listed market and financial metrics rather than operating detail.

Track RUBICON Share Price on Univest

Use RUBICON RESEARCH LIMITED (RUBICON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Frequently Asked Questions

Why is RUBICON Share Price rising today?

Ans. The supplied data confirms a 2.12% rise in RUBICON Share Price to Rs 1,844.00, but it does not establish a company-specific catalyst. The session data only shows the move, range and turnover, not the reason.

What is RUBICON Share Price today?

Ans. RUBICON Share Price today is Rs 1,844.00, up Rs 38.20 from the previous close of Rs 1,805.80. The stock opened at Rs 1,819.30 and traded between Rs 1,782.25 and Rs 1,852.50 during the session.

What is the market capitalisation of RUBICON?

Ans. RUBICON’s market capitalisation is Rs 29,891.75 crore. That places the company above the sector median and average market-cap figures in the supplied Pharmaceuticals & Drugs benchmark, giving RUBICON Share Price strong size context.

Is RUBICON expensive on valuation?

Ans. Based on the supplied numbers, RUBICON trades at a P/E of 103.71 and a P/B of 22.27, both above the sector benchmark and peer set. That means RUBICON Share Price appears premium on valuation measures.

How do RUBICON’s profitability ratios compare with the sector?

Ans. RUBICON reports ROE of 27.84% and ROCE of 29.22%, both above the sector median and average supplied for Pharmaceuticals & Drugs. Those figures give RUBICON Share Price a strong profitability context.

How does RUBICON compare with peer stocks?

Ans. Among the supplied peers, RUBICON has the highest P/E, P/B, ROE and ROCE. Its market capitalisation is below Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals, but above Zydus Lifesciences and Cipla in the table.

What are the key fundamentals behind RUBICON Share Price?

Ans. The main fundamentals are EPS of Rs 17.41, book value of Rs 81.09, dividend yield of 0.08%, ROE of 27.84% and ROCE of 29.22%. These metrics provide a clear financial context for RUBICON Share Price.